Analysts: Jazz Pharmaceuticals PLC (JAZZ.O)

JAZZ.O on Nasdaq

58.49USD
20 May 2013
Price Change (% chg)

$0.13 (+0.22%)
Prev Close
$58.36
Open
$58.36
Day's High
$59.25
Day's Low
$58.36
Volume
461,609
Avg. Vol
754,199
52-wk High
$60.79
52-wk Low
$40.38

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month		 Last Updated
Buy 1.52 December 21 May 2013

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago		 2 Month
Ago		 3 Month
Ago
(1) BUY 9 9 10 8
(2) OUTPERFORM 5 5 4 3
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.36 1.36 1.29 1.27

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-13 12 207.84 216.40 200.30 143.40
Quarter Ending Sep-13 12 216.49 230.20 208.00 --
Year Ending Dec-13 13 848.85 865.40 823.10 817.82
Year Ending Dec-14 12 1,008.51 1,145.47 894.70 996.30
Earnings (per share)
Quarter Ending Jun-13 13 1.52 1.67 1.41 --
Quarter Ending Sep-13 13 1.57 1.71 1.38 --
Year Ending Dec-13 13 6.15 6.36 5.87 5.49
Year Ending Dec-14 12 7.51 8.67 6.83 6.45
LT Growth Rate (%) 5 17.84 26.00 9.90 19.20

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 190.25 196.24 5.98 3.14
Quarter Ending Dec-12 184.02 183.70 0.32 0.17
Quarter Ending Sep-12 179.62 175.51 4.10 2.28
Quarter Ending Jun-12 125.53 129.54 4.01 3.20
Quarter Ending Mar-12 102.48 108.41 5.93 5.79
Earnings (per share)
Quarter Ending Mar-13 1.35 1.37 0.02 1.61
Quarter Ending Dec-12 1.42 1.53 0.11 7.52
Quarter Ending Sep-12 1.32 1.29 0.03 2.35
Quarter Ending Jun-12 1.11 1.09 0.02 1.42
Quarter Ending Mar-12 0.84 0.91 0.07 8.08

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago		 1 Month
Ago		 2 Month
Ago		 1 Year
Ago
SALES (in millions)
Quarter Ending Jun-13 207.84 207.84 201.56 201.50 143.40
Quarter Ending Sep-13 216.49 216.49 211.00 210.72 --
Year Ending Dec-13 848.85 848.85 825.48 824.50 817.82
Year Ending Dec-14 1,008.51 1,008.51 975.40 965.84 996.30
Earnings (per share)
Quarter Ending Jun-13 1.52 1.52 1.46 1.46 --
Quarter Ending Sep-13 1.57 1.57 1.49 1.49 --
Quarter Ending Dec-13 6.15 6.15 5.87 5.86 5.49
Quarter Ending Dec-14 7.51 7.51 7.00 7.14 6.45

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jun-13 0 0 10 1
Quarter Ending Sep-13 0 0 11 0
Year Ending Dec-13 0 0 12 0
Year Ending Dec-14 0 0 9 1
Earnings
Quarter Ending Jun-13 0 0 9 1
Quarter Ending Sep-13 0 0 10 0
Year Ending Dec-13 0 0 10 0
Year Ending Dec-14 0 0 9 0

Earnings vs. Estimates

» More Financials

Jazz Pharmaceuticals PLC News

Analyst Research Reports

Report Title Price
Jazz Pharmaceuticals plc (JAZZ) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Provider: GlobalData
$250.00
Buy
Thomson Reuters Stock Report - JAZZ PHARMACEUTICALS PLC (JAZZ-O)
Provider: Thomson Reuters Stock Report
$25.00
Buy
Market Edge Equity Research Report
Provider: Market Edge
$10.00
Buy
JAZZ PHARMACEUTICALS INC (JAZZ) 12-months forecast
Provider: Pechala's Reports
$15.00
Buy
Jazz Pharmaceuticals PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
$20.00
Buy

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

» More Analyst Research
Search Stocks